SCHEMBL4151194

SCHEMBL4151194

Cc1cc(NC(=O)c2cc3cc(F)ccc3n2Cc2ccncc2)cnc1N(C)C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.41
ECE1 P42892 5/20 0.41
PTGDR2 Q9Y5Y4 5/20 0.41
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
F10 P00742 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MAOB P27338 1/20 0.38
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145734 0.89 F10 (0.46) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL4167504 0.83 MAPT (0.41) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL2892433 0.81 ECE1 (0.56) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL4146220 0.81 F10 (0.47) CCR2ECE1PTGDR2F10MAOB
SCHEMBL4157656 0.81 ECE1 (0.49) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL27829308 0.80 TNIK (0.46) CCR2ECE1MEN1ALDH1A1HPGD
SCHEMBL4151515 0.79 MAPT (0.48) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL4143267 0.79 MAPT (0.42) CCR2ECE1PTGDR2MAPTTP53
SCHEMBL4150715 0.78 F10 (0.48) CCR2ECE1F10MAOB
SCHEMBL15361982 0.78 RAB9A (0.52) PTGDR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481745-B2 N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use therof SANOFI (FR) 2013-07-09 US disclosed
CN-101495469-B Derivatives of N- (amino-heteroaryl) -1H-indole-2-carboxamides as antagonists of TRPV1 or VR1 receptors SANOFI AVENTIS 2013-05-01 CN disclosed
US-20120264944-A1 N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEROF SANOFI (FR) 2012-10-18 US disclosed
EP-2046775-B1 N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-08-22 EP disclosed
US-8227489-B2 N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-07-24 US disclosed
US-20090156809-A1 N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264944-A1 N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEROF IDO2, IDO1, IKZF3 CCR2 1632/4885ECE1 2326/4885PTGDR2 1613/4885
US-20090156809-A1 N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF IDO1, IDO2, CNKSR1 CCR2 912/4885ECE1 1630/4885PTGDR2 871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.